Publication | Closed Access

Serum anti-p53 antibody detection in carcinomas and the predictive values of serum p53 antibodies, carcino-embryonic antigen and carbohydrate antigen 12–5 in the neoadjuvant chemotherapy treatment for III stage non-small cell lung cancer patients

Serum P53 AntibodiesMedicineImmunologyTumor ImmunityPathologyNeoadjuvant Chemotherapy TreatmentCancer TreatmentOncologyMalignant DiseaseLung CancerCancer ResearchCarbohydrate Antigen 12–5